// App-Quantinova.ai

18274 : Under Use of Statins and LDL-C Control Among People With a Framingham 10-Year Coronary Heart Disease Risk > 20%

Researchers

Presenter

  • Emily Levitan

Principal Investigators

  • Devin Mann

  • Huifeng Yun

  • Stephen Glasser

  • J. Michael Woolley

  • Robert Rosenson

  • Michael Farkouh

  • Monika Safford

  • Paul Muntner

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • Mount Sinai School of Medicine, New York, NY

  • Boston Univ., Boston, MA.

  • Mount Sinai Sch of Med, Toronto, ON, Canada

Locations

  • United States

  • Canada

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Coronary Artery Disease

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved